Company Filing History:
Years Active: 2013-2014
Title: **The Innovative Journey of Jennifer L. Gooch**
Introduction
Jennifer L. Gooch, an accomplished inventor based in Lilburn, Georgia, has made significant strides in the field of biomedical research. With a focus on methods that enhance our understanding of calcineurin activity, her work has the potential to transform therapeutic outcomes for patients undergoing organ transplant.
Latest Patents
Jennifer holds two patents, the latest of which includes methods for determining calcineurin activity. This innovative approach involves a fluorescence-based assay designed specifically for isolated T cells. The technique encompasses the use of a reaction mix containing a fluorescently-labeled peptide substrate in conjunction with a TiO matrix, enabling the differentiation of phosphorylated and dephosphorylated peptides. This method not only provides precise measurements of calcineurin activity but also enhances diagnostic accuracy for individuals receiving immunosuppressant therapy post-transplant.
Another notable patent focuses on the methodologies for determining protein kinase or phosphatase activity in biological samples. This groundbreaking work, involving the stimulation of T cells with targeted agents, set a new standard in the field by allowing better assessments of patient responses to therapies.
Career Highlights
Jennifer is associated with Emory University, where her research contributes to advancements in biomedical sciences. Her commitment to innovation and the development of diagnostic methods has earned her respect in her field, solidifying her reputation as a leading figure in biochemistry.
Collaborations
Throughout her career, Jennifer has collaborated with notable colleagues, including Brian R. Roberts and Jan Pohl. These partnerships have fostered an environment of innovation and knowledge exchange, enhancing the depth and reach of their collective research efforts.
Conclusion
In summary, Jennifer L. Gooch exemplifies the spirit of innovation and dedication to scientific advancement. Her patented methodologies for assessing calcineurin activity stand to improve therapeutic practices for organ transplant patients, highlighting her invaluable contributions to the medical research community. As her work continues to evolve, it promises to lead further breakthroughs in understanding cellular responses in immunology.